Discontinuation of Eculizumab Treatment in Atypical Hemolytic Uremic Syndrome: An Update

被引：78
|
作者：
Ardissino, Gianluigi [1 ]
Possenti, Ilaria [1 ]
Tel, Francesca [1 ]
Testa, Sara [1 ]
Salardi, Stefania [1 ]
Ladisa, Vito [1 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr HUS Control, Prevent & Management, Milan, Italy
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2015年 / 66卷 / 01期
关键词：
D O I：
10.1053/j.ajkd.2015.04.010
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 173
页数：3
相关论文
共 50 条
  • [21] Eculizumab for Atypical Hemolytic Uremic Syndrome in Pregnancy
    Ardissino, Gianluigi
    Ossola, Manuela Wally
    Baffero, Giulia Maria
    Rigotti, Angelo
    Cugno, Massimo
    OBSTETRICS AND GYNECOLOGY, 2013, 122 (02): : 487 - 489
  • [22] A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome
    AlZabali, Saeed
    AlBatati, Sawsan
    Rahim, Khawla
    Faqeehi, Hassan
    Osman, Abubaker
    Bamhraz, Abdulaziz
    Saleh, Mohammed A.
    Kari, Jameela A.
    Aloufi, Majed
    Eid, Loai
    Nasser, Haydar
    Imam, Abubakr
    AlHammadi, Entesar
    Alkandari, Omar
    Al Riyami, Mohammed
    Sethi, Sidharth
    Licht, Christoph
    Alhasan, Khalid A.
    AlAnazi, Abdulkarim
    CHILDREN-BASEL, 2022, 9 (11):
  • [23] Outcome of 11 pediatric patients with atypical hemolytic and uremic syndrome after Eculizumab discontinuation
    Fila, M.
    Caillez, M.
    Hogan, J.
    Louillet, F.
    Loirat, C.
    Bacchi, V. Fremeaux
    Fakhouri, F.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1873 - 1873
  • [24] Pharmacokinetics and pharmacodynamics of eculizumab in individualized treatment of atypical hemolytic uremic syndrome
    Volokhina, Elena
    Wijnsma, Kioa
    Sweep, Fred
    Bruggemann, Roger
    Wetzels, Jack
    van de Kar, Nicole
    van den Heuvel, Lambertus
    IMMUNOBIOLOGY, 2016, 221 (10) : 1141 - 1141
  • [25] ECULIZUMAB FOR TREATMENT OF RARE CUTANEOUS INVOLVEMENT IN ATYPICAL HEMOLYTIC UREMIC SYNDROME
    Lopes, Daniela
    Gomes, Ana Marta
    Fernandes, Joao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [26] Successful Treatment of Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab
    Nuernberger, Jens
    Witzke, Oliver
    Rother, Russell P.
    Philipp, Thomas
    Vester, Udo
    Baba, Hideo
    Zimmerhackl, Lothar Bemd
    Kribben, Andreas
    BLOOD, 2008, 112 (11) : 800 - 800
  • [27] Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab
    Gulleroglu, Kaan
    Fidan, Kibriya
    Hancer, Veysel S.
    Bayrakci, Umut
    Baskin, Esra
    Soylemezoglu, Oguz
    PEDIATRIC NEPHROLOGY, 2013, 28 (05) : 827 - 830
  • [28] Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
    Azad, Farhan
    Miranda, Clive J.
    Al Amin
    Hadwani, Ruhi
    Gravina, Matthew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [29] Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab
    Vakiti, Anusha
    Singh, Daulath
    Pilla, Ravi
    Alhaj-Moustafa, Muhamad
    Fitzpatrick, Kelly W.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 1011 - 1015
  • [30] Treatment of Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies: A Focus on Eculizumab
    Schmidtko, Jan
    Peine, Sven
    El-Housseini, Youssef
    Pascual, Manuel
    Meier, Pascal
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (02) : 289 - 299
12345